PU-WS13
PU-WS13 Basic information
- Product Name:
- PU-WS13
- Synonyms:
-
- PU-WS13
- 8-((3,5-dichlorophenyl)thio)-9-(3-(isopropylamino)propyl)-9H-purin-6-amine
- 6-Amino-8-[(3,5-dichlorophenyl)thio]-N-(1-methylethyl)-9H-purine-9-propanamine
- 8-(3,5-dichlorophenyl)sulfanyl-9-[3-(propan-2-ylamino)propyl]purin-6-amine
- PU WS13;PUWS13
- CS-1689
- CS-2047
- 9H-Purine-9-propanamine, 6-amino-8-[(3,5-dichlorophenyl)thio]-N-(1-methylethyl)-
- CAS:
- 1454619-14-7
- MF:
- C17H20Cl2N6S
- MW:
- 411.35
- Mol File:
- 1454619-14-7.mol
PU-WS13 Chemical Properties
- Boiling point:
- 617.4±65.0 °C(Predicted)
- Density
- 1.47±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C(protect from light)
- solubility
- DMF: 30 mg/mL,DMSO: 30 mg/mL,DMSO:PBS(pH7.2) (1:1): 0.5 mg/mL,Ethanol: 25 mg/mL
- form
- Powder
- pka
- 10.15±0.29(Predicted)
- color
- White to off-white
PU-WS13 Usage And Synthesis
Description
PU-WS13 is an inhibitor of the heat shock protein family member and chaperone protein glucose-regulated protein 94 (GRP94; IC50 = 0.22 μM). It is selective for GRP94 over the chaperones Hsp90α, Hsp90β, and TRAP1 (IC50s = 27.3, 41.8, and 7.3 μM, respectively). PU-WS13 (0.5, 2.5, and 12.5 μM) induces apoptosis without increasing Hsp70 protein levels in HER2-overexpressing SK-BR-3, BT474, and MDA-MB-361 breast cancer cells. It also induces apoptosis and necrosis in multiple myeloma cells but does not induces cell death in pre-B leukemic cells.
Uses
PU-WS13 is a pharmaceutical agent used in the preparation go paralog=selective HSP90 inhibitors used in anti-tumor treatments.
IC 50
GRP94: 0.22 μM (EC50); HSP90α: 27.3 μM (EC50); HSP90β: 41.8 μM (EC50); TRAP-1: 7.3 μM (EC50)
PU-WS13Supplier
- Tel
- sales@boylechem.com
- Tel
- 021-58950125
- info@chemexpress.com
- Tel
- 021-58955995
- sales@medchemexpress.cn
- Tel
- 0551-66399836 18955197623
- sales@enlipharma.com
- Tel
- 0571-82693216
- info@yuhaochemical.com